Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
3
×
national blog main
ucla
3
×
abbvie
clinical trials
fda
national top stories
access biotechnology
access industries
alirocumab
alkermes
allergan
amgen
anemia
atlas ventures
blood diseases
blood disorders
boston
boulder/denver blog main
boulder/denver top stories
brian macdonald
buprenorphine
cardiac
cardiovascular
cariprazine
cause of death
cedar-sinai
cholesterol
circulation
clinical studies
david maron
detroit blog main
detroit top stories
disc medicine
drug development
eli lilly
elizabeta nemeth
What
drug
medicine
new
advance
alkermes
anemia
antipsychotic
benefits
blood
body
carry
caveats
cells
cholesterol
commonly
designed
disc
drugs
effect
expensive
faces
favor
fda
financial
foe
gain
having
health
healthcare
hint
inhibitors
iron
known
launches
lead
little
lowering
lungs
need
offer
Language
unset
Current search:
ucla
×
" life sciences "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
